Our team has a busy November ahead of us, and we’re excited to connect with faces old and new as we continue expanding our reach.
From November 17th – 20th, we’ll be in Boca Raton, FL for this year’s CNS Summit! If you’re attending, you can learn more about our capabilities in the CNS space by talking with one of our staff members or alliance partners in attendance:
hyperCORE Executive Director, Michael Casey
hyperCORE CEO & Centricity Research COO/President, Karri Venn
hyperCORE Chief Medical Officer & AGA CLINICAL TRIALS VP, ROBERTO AGUIRRE MD, CPI, CCRP
hyperCORE Co-Chief Diversity Officer & CEO of Quality Clinical Research, Inc, Seneca Harrison
hyperCORE Co-Chief Diversity Officer & CEO of Alcanza Clinical Research, Carlos E. Orantes
Centricity Research Executive Director of Business & Development, Felicia Irvin
Benchmark Research Site Director, Brian K. Wooten, BS, MA, CCRC
You can also catch Felicia Irvin this Friday during the summit as she speaks during one of the conference sessions!
November 18, 12:00 to 12:50 PM
“Connecting people, data, and technology to make a substantial, lasting, and measurable impact on patient and site burden”
Abstract: The pharma industry’s strong focus on alleviating patient and site burden in clinical trials stems from the effect burden has on study success. But it’s a hard goal to achieve – for a single study, let alone at scale across an entire portfolio of trials. Stakeholders from different facets of the clinical trial industry – patient, site, sponsor, and data/tech/service providers – will come together to discuss what patient and site burden means to them; how it is addressed in clinical trial planning and execution today; what meaningful improvement looks like; and how we can connect people, data, and technology to make significant, sustainable improvements for all.
Later in the month from November 28th – December 1st, Michael Casey and Felicia Irvin will head to San Diego, California to join Van Johnson, VP of Commercial Strategy at Benchmark Research for World Vaccine & Immunotherapy Congress West Coast! We’ll be joining our VaxCorps colleagues as we learn more about the ground-breaking work being done for vaccine research and immunotherapies, and hopefully connecting with new industry professionals and developing exciting partnerships.
Will we see you there?